NCT03417037 An Immuno-Therapy Study of Experimental Medication BMS-986205 Given With Nivolumab With or Without Chemotherapy Compared to Chemotherapy in Participants With Previously Untreated Stage IV or Recurrent Non-Small Cell Lung Cancer Status WITHDRAWN Phase PHASE3
NCT03410693 Study of Rogaratinib (BAY1163877) vs Chemotherapy in Patients With FGFR (Fibroblast Growth Factor Receptor)-Positive Locally Advanced or Metastatic Urothelial Carcinoma Status COMPLETED Phase PHASE2/PHASE3
NCT03399253 Chemotherapy Alone Versus Surgery Plus Chemotherapy for Distal Gastric Cancer With One Non-curable Factor Status RECRUITING Phase PHASE2/PHASE3
NCT03393741 Pharmacodynamic Biomarkers of Standard Anti-microtubule Drugs as Assessed by Early Tumor Biopsy Status TERMINATED Phase N/A
NCT03386162 SAFIR-PI3K A Phase II Randomized Maintenance Trial Comparing Alpelisib and Fulvestrant Versus Chemotherapy in PIK3CA Mutated Advanced Breast Cancer Status TERMINATED Phase PHASE2
NCT03353831 Atezolizumab With Bevacizumab and Chemotherapy vs Bevacizumab and Chemotherapy in Early Relapse Ovarian Cancer Status COMPLETED Phase PHASE3
NCT03353675 A Study Evaluating the Efficacy and the Safety of First-line Chemotherapy Combined With the Therapeutic Vaccine Named TG4010 and Nivolumab in Patients With Advanced Non-squamous Non-Small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE2
NCT03351361 Nivolumab and Ipilimumab Versus Chimiotherapy in First Line Treatment in PS 2 or Elderly in Advanced NSCLC Patients Status COMPLETED Phase PHASE3
NCT03348241 Using Gum Arabic for Cancer Patients to Protect From Oral Mucositis Caused by Chemotherapy: ِِِAn Experimental Study Status COMPLETED Phase PHASE2
NCT03344068 Early and Whole Course Nutritional Support by Nutren® Optimum During IMRT for Nasopharyngeal Carcinoma Status UNKNOWN Phase PHASE2/PHASE3
NCT03329950 A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies Status COMPLETED Phase PHASE1
NCT03283384 Tailoring NEOadjuvant Therapy in Hormone Receptor Positive, HER2 Negative, Luminal Breast Cancer. Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03248570 Pembrolizumab in Metastatic Castration Resistant Prostate Cancer (mCRPC) With or Without DNA Damage Repair Defects Status COMPLETED Phase PHASE2
NCT03242551 Biomarkers Investigation of Neoadjuvant Chemotherapy for Breast Cancer Status UNKNOWN Phase PHASE2
NCT03236857 A Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory Malignancies Status COMPLETED Phase PHASE1
NCT03234842 Dose Escalated Proton Beam Therapy or Photon Therapy for Esophageal Cancer Status WITHDRAWN Phase PHASE2
NCT03199144 Neoadjuvant Chemotherapy and Stereotactic Radiosurgery to Pancreatectomy for Patients With Borderline Resectable Pancreatic Cancer Status WITHDRAWN Phase PHASE2